![Li Ju Yeh](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Li Ju Yeh
Directeur/Membre du Conseil chez DELTA ASIA INTERNATIONAL CORPORATION
Postes actifs de Li Ju Yeh
Sociétés | Poste | Début | Fin |
---|---|---|---|
DELTA ASIA INTERNATIONAL CORPORATION | Directeur/Membre du Conseil | 12/11/2019 | - |
Independent Dir/Board Member | 12/11/2019 | - | |
TRICORNTECH TAIWAN CORPORATION | Directeur/Membre du Conseil | - | - |
Independent Dir/Board Member | - | - |
Historique de carrière de Li Ju Yeh
Anciens postes connus de Li Ju Yeh
Sociétés | Poste | Début | Fin |
---|---|---|---|
TWI BIOTECHNOLOGY, INC. | Comptroller/Controller/Auditor | 18/06/2013 | 01/09/2019 |
Directeur Financier/CFO | 18/06/2013 | 01/09/2019 | |
Public Communications Contact | - | 01/09/2019 | |
Sales & Marketing | 18/06/2013 | - | |
TWI PHARMACEUTICALS INC | Comptroller/Controller/Auditor | 01/12/2011 | - |
Directeur Financier/CFO | 01/12/2011 | - | |
Public Communications Contact | 01/12/2011 | - |
Formation de Li Ju Yeh
National Sun Yat-Sen University | Graduate Degree |
Statistiques
Internationale
Taïwan | 6 |
Opérationnelle
Comptroller/Controller/Auditor | 2 |
Director of Finance/CFO | 2 |
Public Communications Contact | 2 |
Sectorielle
Health Technology | 4 |
Consumer Services | 2 |
Electronic Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 3 |
---|---|
TWI BIOTECHNOLOGY, INC. | Health Technology |
DELTA ASIA INTERNATIONAL CORPORATION | Health Technology |
TRICORNTECH TAIWAN CORPORATION | Electronic Technology |
Entreprise privées | 1 |
---|---|
TWi Pharmaceuticals, Inc.
![]() TWi Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology TWi Pharmaceuticals, Inc. operates as a technology-based special pharmaceutical company. The firm engages in the development and commercialization of high barrier generics drugs. Its products include donepezil hydrochloride tablets, megestrol acetate oral suspension, hydroquinone cream, guanfacine extended-release tablets and nifedipine extended-release tablets. The company was founded by Chih Ming Chen on December 1, 1997 and is headquartered in Taipei, Taiwan. | Health Technology |